1. Home
  2. KELYB vs ZVRA Comparison

KELYB vs ZVRA Comparison

Compare KELYB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

HOLD

Current Price

$23.16

Market Cap

758.9M

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$12.51

Market Cap

766.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
ZVRA
Founded
1946
2006
Country
United States
United States
Employees
4900
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
758.9M
766.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
KELYB
ZVRA
Price
$23.16
$12.51
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
1.2K
1.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.60
Revenue
N/A
$106,470,000.00
Revenue This Year
$0.72
$37.27
Revenue Next Year
N/A
$53.42
P/E Ratio
N/A
$20.23
Revenue Growth
N/A
350.91
52 Week Low
$8.38
$7.16
52 Week High
$125.00
$15.04

Technical Indicators

Market Signals
Indicator
KELYB
ZVRA
Relative Strength Index (RSI) 60.03 39.59
Support Level $11.84 $8.26
Resistance Level $125.00 $12.05
Average True Range (ATR) 1.63 0.66
MACD 0.06 -0.27
Stochastic Oscillator 72.49 1.57

Price Performance

Historical Comparison
KELYB
ZVRA

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: